Alpha-adrenergic receptor and Beta-adrenergic receptor (None universally accepted for both combined; commonly abbreviated individually as "α-adrenergic receptor (α-AR)" and "β-adrenergic receptor (β-AR)")

Alpha-adrenergic receptors and beta-adrenergic receptors are classes of G protein-coupled receptors that mediate the physiological actions of catecholamines such as epinephrine and norepinephrine. They are divided into subfamilies (α1, α2, β1, β2, β3), each with distinct tissue localization and functional roles. Alpha receptors primarily mediate vasoconstriction and increased blood pressure, while beta receptors mediate increased heart rate, contractility, bronchodilation, and metabolic effects. Both are essential in regulating the body’s response to stress ("fight or flight"), and they are therapeutic targets for drugs treating cardiovascular, pulmonary, and other disorders. Due to their widespread physiological impact, careful targeting and patient selection are important in pharmacotherapy involving these receptors. In summary, "Alpha-adrenergic receptor and Beta-adrenergic receptor" refers to multiple related but distinct therapeutic targets. For structured drug discovery or clinical data, specifying the exact subtype is recommended.

Other names

Adrenergic receptorAdrenoceptorAlpha receptor (for α-adrenergic receptor)Beta receptor (for β-adrenergic receptor)Catecholamine receptorSympathetic receptor

Agonists activate receptors to mimic sympathetic nervous system effects: vasoconstriction (alpha-1), decreased transmitter release (alpha-2), increased heart rate and contractility (beta-1), bronchodilation and smooth muscle relaxation (beta-2). Antagonists block the action of endogenous catecholamines, leading to effects such as vasodilation (alpha-blockers), reduced heart rate and contractility (beta-blockers), and decreased blood pressure. Receptor-specific intracellular pathways: Gq (alpha-1), Gi (alpha-2, some beta), Gs (all beta).